-
Something wrong with this record ?
Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma
F Petersson, P Grossmann, M Hora, M Sperga, DP Montiel, P Martinek, ME Gutierrez, S Bulimbasic, M Michal, J Branzovsky, O Hes
Language English Country United States
Grant support
NT12010
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2012-09-01 to 2015-07-31
- MeSH
- Adenoma * diagnostic imaging MeSH
- Angiomyoma * diagnosis MeSH
- Chromosome Aberrations MeSH
- Diagnosis, Differential MeSH
- Adult MeSH
- Carcinoma, Renal Cell * diagnosis MeSH
- Keratin-7 metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Chromosomes, Human, Pair 17 MeSH
- Chromosomes, Human, Pair 7 MeSH
- Neoplasms, Multiple Primary diagnosis MeSH
- Mutation MeSH
- Von Hippel-Lindau Tumor Suppressor Protein genetics MeSH
- Kidney Neoplasms * diagnosis MeSH
- Carcinoma, Papillary * diagnosis MeSH
- Racemases and Epimerases metabolism MeSH
- Aged MeSH
- von Hippel-Lindau Disease MeSH
- Loss of Heterozygosity MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
We present a cohort of 8 renal carcinomas that displayed a variable (5%-95% extent) light microscopic appearance of renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma (RAT/CCPRCC) without fulfilling the criteria for these tumors. All but 1 case predominantly (75%-95% extent) showed histopathologic features of conventional clear cell renal cell carcinoma. In 5 of 7 cases with mostly conventional clear renal cell carcinoma (CRCC) morphology, a diagnosis of CRCC was supported by the molecular genetic findings (presence of von Hippel-Lindau tumor suppressor [VHL] mutation and/or VHL promoter methylation and/or loss of heterozygosity [LOH] for 3p). Of the other 2 cases with predominantly characteristic CRCC morphology, 1 tumor did not reveal any VHL mutation, VHL promoter methylation, or LOH for 3p, and both chromosomes 7 and 17 were disomic, whereas the other tumor displayed polysomy for chromosomes 7 and 17 and no VHL mutation, VHL promoter methylation, or LOH for 3p. One tumor was composed primarily (95%) of distinctly RAT/CCPRCC-like morphology, and this tumor harbored a VHL mutation and displayed polysomy for chromosomes 7 and 17. Of the 5 cases with both histomorphologic features and molecular genetic findings of CRCC, we detected significant immunoreactivity for alpha-methylacyl-CoA racemase in 2 cases and strong diffuse immunopositivity for cytokeratin 7 in 3 cases. Despite the combination of positivity for alpha-methylacyl-CoA racemase and cytokeratin 7 in 2 cases, there was nothing to suggest of the possibility of a conventional papillary renal cell carcinoma with a predominance of clear cells.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18038392
- 003
- CZ-PrNML
- 005
- 20241120102823.0
- 007
- ta
- 008
- 181121s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.humpath.2012.11.019 $2 doi
- 035 __
- $a (PubMed)23434146
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Petersson, Fredrik $u Petersson, Fredrik. Department of Pathology, National University Health System, Singapore, Singapore.
- 245 10
- $a Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma / $c F Petersson, P Grossmann, M Hora, M Sperga, DP Montiel, P Martinek, ME Gutierrez, S Bulimbasic, M Michal, J Branzovsky, O Hes
- 520 9_
- $a We present a cohort of 8 renal carcinomas that displayed a variable (5%-95% extent) light microscopic appearance of renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma (RAT/CCPRCC) without fulfilling the criteria for these tumors. All but 1 case predominantly (75%-95% extent) showed histopathologic features of conventional clear cell renal cell carcinoma. In 5 of 7 cases with mostly conventional clear renal cell carcinoma (CRCC) morphology, a diagnosis of CRCC was supported by the molecular genetic findings (presence of von Hippel-Lindau tumor suppressor [VHL] mutation and/or VHL promoter methylation and/or loss of heterozygosity [LOH] for 3p). Of the other 2 cases with predominantly characteristic CRCC morphology, 1 tumor did not reveal any VHL mutation, VHL promoter methylation, or LOH for 3p, and both chromosomes 7 and 17 were disomic, whereas the other tumor displayed polysomy for chromosomes 7 and 17 and no VHL mutation, VHL promoter methylation, or LOH for 3p. One tumor was composed primarily (95%) of distinctly RAT/CCPRCC-like morphology, and this tumor harbored a VHL mutation and displayed polysomy for chromosomes 7 and 17. Of the 5 cases with both histomorphologic features and molecular genetic findings of CRCC, we detected significant immunoreactivity for alpha-methylacyl-CoA racemase in 2 cases and strong diffuse immunopositivity for cytokeratin 7 in 3 cases. Despite the combination of positivity for alpha-methylacyl-CoA racemase and cytokeratin 7 in 2 cases, there was nothing to suggest of the possibility of a conventional papillary renal cell carcinoma with a predominance of clear cells.<ovid:br /><ovid:br />Copyright © 2013 Elsevier Inc. All rights reserved.
- 590 __
- $a bohemika - dle Pubmed
- 650 12
- $a adenom $x diagnostické zobrazování $7 D000236
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a senioři $7 D000368
- 650 12
- $a angiomyom $x diagnóza $7 D018229
- 650 12
- $a papilární karcinom $x diagnóza $7 D002291
- 650 12
- $a karcinom z renálních buněk $x diagnóza $7 D002292
- 650 02
- $a chromozomální aberace $7 D002869
- 650 02
- $a lidské chromozomy, pár 17 $7 D002886
- 650 02
- $a lidské chromozomy, pár 7 $7 D002897
- 650 02
- $a diferenciální diagnóza $7 D003937
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a keratin-7 $x metabolismus $7 D053552
- 650 12
- $a nádory ledvin $x diagnóza $7 D007680
- 650 02
- $a ztráta heterozygozity $7 D019656
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a mutace $7 D009154
- 650 02
- $a mnohočetné primární nádory $x diagnóza $7 D009378
- 650 02
- $a racemasy a epimerasy $x metabolismus $7 D019998
- 650 02
- $a nádorový supresorový protein VHL $x genetika $7 D051794
- 650 02
- $a von Hippelova-Lindauova nemoc $7 D006623
- 650 _2
- $a lidé $7 D006801
- 700 1_
- $a Grossmann, Petr $7 xx0108998
- 700 1_
- $a Hora, Milan, $d 1967- $7 mzk2004258359
- 700 1_
- $a Sperga, M
- 700 1_
- $a Montiel DP
- 700 1_
- $a Martínek, Petr $7 xx0243624
- 700 1_
- $a Gutierrez ME
- 700 1_
- $a Bulimbasic S
- 700 1_
- $a Michal, Michal, $d 1959- $7 jn20001103501
- 700 1_
- $a Branžovský, Jindřich, $d 1987- $7 xx0324720
- 700 1_
- $a Hes, Ondřej, $d 1968- $7 jn20001103502
- 773 0_
- $t Human Pathology $g Roč. 44, č. 7 (2013), s. 1412-1420 $p Hum Pathol $x 0046-8177 $w MED00002080
- 773 0_
- $p Hum Pathol $g 44(7):1412-20, 2013 Jul
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20181121142553 $b ABA008
- 991 __
- $a 20241120102818 $b ABA008
- 999 __
- $a ok $b bmc $g 1352927 $s 1035431
- BAS __
- $a 3
- BMC __
- $a 2013 $b 44 $c 7 $d 1412-1420 $x MED00002080 $i 0046-8177 $m Human pathology
- GRA __
- $a NT12010 $p MZ0
- LZP __
- $a NLK 2018/lp